Related Experiment Video
Updated: May 29, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
Published on: June 14, 2020
Identification of the myelin oligodendrocyte glycoprotein as a cellular receptor for rubella virus
Haolong Cong1, Yue Jiang, Po Tien
1Center for Molecular Virology, CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, People's Republic of China.
Abstract:
Rubella virus (RV) is a highly transmissible pathogenic agent that causes the disease rubella. Maternal RV infection during early pregnancy causes the death of the fetus or congenital rubella syndrome in infants. However, the cellular receptor for RV has not yet been identified. In this study, we found that the myelin oligodendrocyte glycoprotein (MOG) specifically bound to the E1 envelope glycoprotein of RV, and an antibody against MOG could block RV infection. Most importantly, we also showed that ectopic expression of MOG on the cell surface of 293T cells rendered this nonpermissive cell line permissive for RV entry and replication. Thus, this study has identified a cellular receptor for RV and suggests that blocking the MOG attachment site of RV may be a strategy for molecular intervention of RV infection.
Insights
Researchers identified the myelin oligodendrocyte glycoprotein (MOG) as the cellular receptor for rubella virus (RV). Blocking MOG attachment may prevent RV infection, offering a new therapeutic strategy for rubella.
Area of Science:
- Virology
- Immunology
- Neuroscience
Background:
- Rubella virus (RV) causes significant health issues, including congenital rubella syndrome.
- The cellular receptor for RV, crucial for understanding its entry mechanism, remained unidentified.
- Identifying the RV receptor is vital for developing targeted interventions.
Purpose of the Study:
- To identify the cellular receptor for rubella virus (RV).
- To investigate the role of myelin oligodendrocyte glycoprotein (MOG) in RV infection.
- To explore MOG as a potential target for blocking RV entry.
Main Methods:
- Protein binding assays to test interactions between RV E1 glycoprotein and potential cellular receptors.
- Neutralization assays using antibodies against MOG to block RV infection.
- Genetic engineering to express MOG on non-permissive cells (293T) and assess RV replication.
Main Results:
- Myelin oligodendrocyte glycoprotein (MOG) was found to specifically bind to the E1 envelope glycoprotein of RV.
- An antibody targeting MOG effectively blocked RV infection in vitro.
- Ectopic expression of MOG on 293T cells enabled RV entry and replication, confirming MOG's role as a functional receptor.
Conclusions:
- Myelin oligodendrocyte glycoprotein (MOG) is identified as the cellular receptor for rubella virus (RV).
- MOG facilitates RV entry into host cells.
- Targeting the MOG-RV interaction presents a promising strategy for preventing or treating rubella infections.
Related Concept Videos
Rabies
Respiratory Syncytial Virus Disease
